Undruggable registry
Cross-session targets blocked from direct modulation
Cross-session learning
Targets where direct modulation is not pursued
Arclight records targets that fail three-modality druggability screening. Future discovery programs inherit this registry automatically — avoiding repeated dead-end routes. Rescan-eligible entries may be reconsidered on a manual target re-screen; automatic literature monitoring is not active yet.
Registry entries
0
Unique targets
0
Global blocks
0
Rescan eligible
0
How the registry is used
During Phase 2 target screening, entries here pre-block targets before expensive drug-branch steps run. Session assessments are promoted into this list when a primary target fails across small molecule, biologic, and ADC modalities. Global entries apply to all future discoveries.Loading registry…